IPCA Labs is the top Nifty Pharma gainer, set for best calendar year returns since 2020

Before two successive years of positive returns, the shares of IPCA Laboratories had declined 22% in 2022 and 1.1% in 2021.

Leave a Reply

Your email address will not be published. Required fields are marked *